Source: https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title22-chapter83&saved=%7CZ3JhbnVsZWlkOlVTQy1wcmVsaW0tdGl0bGUyMi1zZWN0aW9uNzYxMg%3D%3D%7C%7C%7C0%7Cfalse%7Cprelim&edition=prelim
Timestamp: 2020-04-01 18:26:57
Document Index: 468044949

Matched Legal Cases: ['§3', '§3', '§2151', '§4', '§4', '§7604', '§5', '§5', '§301', '§595', '§301', '§2151', '§301', '§301', '§595', '§7631', '§203', '§302', '§302', '§2151', '§302', '§7633', '§303', '§303', '§2151', '§303', '§303', '§303', '§7634', '§304', '§304', '§305', '§7636', '§307', '§311', '§312', '§307', '§307', '§313', '§308', '§314', '§315', '§7671', '§401', '§401', '§7672', '§402', '§402', '§7673', '§403', '§403', '§6', '§4', '§4', '§4', '§6', '§6', '§403', '§403', '§403', '§7674', '§404', '§7681', '§502', '§7682', '§503']

[USC02] 22 USC Ch. 83: UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBERCULOSIS, AND MALARIA
<< Previous TITLE 22 / CHAPTER 83 Next >>
22 USC Ch. 83: UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBERCULOSIS, AND MALARIA
CHAPTER 83—UNITED STATES LEADERSHIP AGAINST HIV/AIDS, TUBERCULOSIS, AND MALARIA
Authority to consolidate and combine reports.
Development of a comprehensive, five-year, global strategy.
HIV/AIDS response Coordinator.
7612a.
HIV/AIDS Working Capital Fund.
Sense of Congress on public-private partnerships.
Combating HIV/AIDS, tuberculosis, and malaria by strengthening health policies and health systems of partner countries.
Facilitating vaccine development.
SUBCHAPTER III—BILATERAL EFFORTS
Part A—General Assistance and Programs
7631a.
Authorization of appropriations to combat tuberculosis.
Malaria response Coordinator.
Report on treatment activities by relevant executive branch agencies.
Study on illegal diversions of prescription drugs.
Part B—Assistance for Children and Families
Annual reports on prevention of mother-to-child transmission of the HIV infection.
Pilot program of assistance for children and families affected by HIV/AIDS.
Pilot program on family survival partnerships.
Assistance from the United States private sector to prevent and reduce HIV/AIDS in sub-Saharan Africa.
SUBCHAPTER V—INTERNATIONAL FINANCIAL INSTITUTIONS
Report on expansion of debt relief to non-HIPC countries.
The term "appropriate congressional committees" means the Committee on Foreign Relations of the Senate and the Committee on Foreign Affairs of the House of Representatives, the Committee on Appropriations of the Senate, and the Committee on Appropriations of the House of Representatives.
The term "paraprofessional" means an individual who is trained and employed as a health agent for the provision of basic assistance in the identification, prevention, or treatment of illness or disability.
The term "partner government" means a government with which the United States is working to provide assistance to combat HIV/AIDS, tuberculosis, or malaria on behalf of people living within the jurisdiction of such government.
(11) Program monitoring
The term "program monitoring" means the collection, analysis, and use of routine program data to determine—
(A) how well a program is carried out; and
(B) how much the program costs.
The term "relevant executive branch agencies" means the Department of State, the United States Agency for International Development, and any other department or agency of the United States that participates in international HIV/AIDS activities pursuant to the authorities of such department or agency or the Foreign Assistance Act of 1961 [22 U.S.C. 2151 et seq.].
(Pub. L. 108–25, §3, May 27, 2003, 117 Stat. 717; Pub. L. 110–293, §3, July 30, 2008, 122 Stat. 2921.)
This chapter, referred to in text, was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
The Foreign Assistance Act of 1961, referred to in par. (12), is Pub. L. 87–195, Sept. 4, 1961, 75 Stat. 424, which is classified principally to chapter 32 (§2151 et seq.) of this title. For complete classification of this Act to the Code, see Short Title note set out under section 2151 of this title and Tables.
2008—Pub. L. 110–293 substituted "Committee on Foreign Affairs of the House of Representatives, the Committee on Appropriations of the Senate, and the Committee on Appropriations" for "Committee on International Relations" in par. (2), added pars. (3) and (7) to (11), and redesignated former pars. (3) to (5) and (6) as (4) to (6) and (12), respectively.
(1) establishing comprehensive, coordinated, and integrated 5-year, global strategies to combat HIV/AIDS, tuberculosis, and malaria by—
(3) intensifying efforts to—
(5) reinforcing efforts to—
(6) helping partner countries to—
(Pub. L. 108–25, §4, May 27, 2003, 117 Stat. 717; Pub. L. 110–293, §4, July 30, 2008, 122 Stat. 2922.)
2008—Pub. L. 110–293 amended section generally. Prior to amendment, section stated the purpose of this chapter.
§7604. Authority to consolidate and combine reports
With respect to the reports required by this chapter to be submitted by the President, to ensure an efficient use of resources, the President may, in his discretion and notwithstanding any other provision of this chapter, consolidate or combine any of these reports, except for the report required by section 7611 of this title, so long as the required elements of each report are addressed and reported within a 90-day period from the original deadline date for submission of the report specified in this chapter. The President may also enter into contracts with organizations with relevant expertise to develop, originate, or contribute to any of the reports required by this chapter to be submitted by the President, with the exception of the 5-year strategy.
(Pub. L. 108–25, §5, May 27, 2003, 117 Stat. 718; Pub. L. 110–293, §5, July 30, 2008, 122 Stat. 2922.)
2008—Pub. L. 110–293 inserted ", with the exception of the 5-year strategy" before the period at end.
As indicated in the report produced by the Institute of Medicine, entitled "PEPFAR Implementation: Progress and Promise", inadequate caloric intake has been clearly identified as a principal reason for failure of clinical response to antiretroviral therapy. In recognition of the impact of malnutrition as a clinical health issue for many persons living with HIV/AIDS that is often associated with health and economic impacts on these individuals and their families, the Global AIDS Coordinator and the Administrator of the United States Agency for International Development shall—
An organization, including a faith-based organization, that is otherwise eligible to receive assistance under section 104A of the Foreign Assistance Act of 1961 [22 U.S.C. 2151b–2], under this chapter, or under any amendment made by this chapter or by the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, for HIV/AIDS prevention, treatment, or care—
(Pub. L. 108–25, title III, §301, May 27, 2003, 117 Stat. 728; Pub. L. 108–199, div. D, title V, §595(3), Jan. 23, 2004, 118 Stat. 209; Pub. L. 110–293, title III, §301(f)–(h), July 30, 2008, 122 Stat. 2956, 2957.)
The Foreign Assistance Act of 1961, referred to in subsec. (b)(1), is Pub. L. 87–195, Sept. 4, 1961, 75 Stat. 424, as amended, which is classified principally to chapter 32 (§2151 et seq.) of this title. For complete classification of this Act to the Code, see Short Title note set out under section 2151 of this title and Tables.
This chapter, referred to in subsecs. (d) to (f), was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
2008—Subsec. (b)(1), (3). Pub. L. 110–293, §301(f), substituted "fiscal years 2009 through 2013" for "fiscal years 2004 through 2008".
Subsec. (c). Pub. L. 110–293, §301(g), amended subsec. (c) generally. Prior to amendment, text read as follows: "In recognition of the fact that malnutrition may hasten the progression of HIV to AIDS and may exacerbate the decline among AIDS patients leading to a shorter life span, the Administrator of the United States Agency for International Development shall, as appropriate—
2004—Subsec. (f). Pub. L. 108–199, §595(3), inserted ", except that this subsection shall not apply to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Health Organization, the International AIDS Vaccine Initiative or to any United Nations agency" after "trafficking".
§7631a. United States Agency for International Development
The Administrator of the United States Agency for International Development, in coordination with the Coordinator of United States Government Activities to Combat HIV/AIDS Globally, may facilitate availability and accessibility of microbicides, provided that such pharmaceuticals are approved, tentatively approved, or otherwise authorized for use by—
(A) the Food and Drug Administration;
(B) a stringent regulatory agency acceptable to the Secretary of Health and Human Services; or
(C) a quality assurance mechanism acceptable to the Secretary of Health and Human Services.
Of the amounts authorized to be appropriated under section 7671 of this title for HIV/AIDS assistance, there are authorized to be appropriated to the President such sums as may be necessary for each of the fiscal years 2009 through 2013 to carry out this section.
(Pub. L. 110–293, title II, §203(e), July 30, 2008, 122 Stat. 2941.)
(Pub. L. 108–25, title III, §302(b), May 27, 2003, 117 Stat. 736; Pub. L. 110–293, title III, §302(f), July 30, 2008, 122 Stat. 2959.)
The Foreign Assistance Act of 1961, referred to in par. (1), is Pub. L. 87–195, Sept. 4, 1961, 75 Stat. 424, as amended, which is classified principally to chapter 32 (§2151 et seq.) of this title. For complete classification of this Act to the Code, see Short Title note set out under section 2151 of this title and Tables.
2008—Par. (1). Pub. L. 110–293, §302(f)(1), substituted "a total of $4,000,000,000 for the 5-year period beginning on October 1, 2008." for "such sums as may be necessary for each of the fiscal years 2004 through 2008".
§7633. Assistance to combat malaria
In addition to funds available under section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 2151b(c)) for such purpose or under any other provision of that Act [22 U.S.C. 2151 et seq.], there are authorized to be appropriated to the President, from amounts authorized to be appropriated under section 7671 of this title, $5,000,000,000 during the 5-year period beginning on October 1, 2008 to carry out section 104C of the Foreign Assistance Act of 1961, as added by subsection (a) [22 U.S.C. 2151b–4], including for the development of anti-malarial pharmaceuticals by the Medicines for Malaria Venture.
Unobligated balances of funds made available for fiscal year 2001, 2002, or 2003 under section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 2151b(c) 1 (as in effect immediately before May 27, 2003) and made available for the control of malaria shall be transferred to, merged with, and made available for the same purposes as funds made available for fiscal years 2009 through 2013 under paragraph (1).
Providing assistance for the prevention, control, treatment, and the ultimate eradication of malaria is—
(1) a major objective of the foreign assistance program of the United States; and
(2) 1 component of a comprehensive United States global health strategy to reduce disease burdens and strengthen communities around the world.
(d) Development of a comprehensive 5-Year strategy
The President shall establish a comprehensive, 5-year strategy to combat global malaria that—
(1) strengthens the capacity of the United States to be an effective leader of international efforts to reduce 2 malaria burden;
(2) maintains sufficient flexibility and remains responsive to the ever-changing nature of the global malaria challenge;
(3) includes specific objectives and multisectoral approaches and strategies to reduce the prevalence, mortality, incidence, and spread of malaria;
(4) describes how this strategy would contribute to the United States' overall global health and development goals;
(5) clearly explains how outlined activities will interact with other United States Government global health activities, including the 5-year global AIDS strategy required under this chapter;
(6) expands public-private partnerships and leverage of resources;
(7) coordinates among relevant Federal agencies to maximize human and financial resources and to reduce duplication among these agencies, foreign governments, and international organizations;
(8) coordinates with other international entities, including the Global Fund;
(9) maximizes United States capabilities in the areas of technical assistance and training and research, including vaccine research; and
(10) establishes priorities and selection criteria for the distribution of resources based on factors such as—
(A) the size and demographics of the population with malaria;
(B) the needs of that population;
(C) the country's existing infrastructure; and
(D) the ability to closely coordinate United States Government efforts with national malaria control plans of partner countries.
(Pub. L. 108–25, title III, §303, May 27, 2003, 117 Stat. 736; Pub. L. 110–293, title III, §303(b), July 30, 2008, 122 Stat. 2960.)
The Foreign Assistance Act of 1961, referred to in subsec. (b)(1), is Pub. L. 87–195, Sept. 4, 1961, 75 Stat. 424, which is classified principally to chapter 32 (§2151 et seq.) of this title. For complete classification of this Act to the Code, see Short Title note set out under section 2151 of this title and Tables.
This chapter, referred to in subsec. (d)(5), was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
Section is comprised of section 303 of Pub. L. 108–25. Subsec. (a) and another subsec. (c) of section 303 of Pub. L. 108–25, respectively, enacted section 2151b–4 of this title and amended section 2151b of this title.
2008—Subsec. (b)(1). Pub. L. 110–293, §303(b)(1)(A), substituted "$5,000,000,000 during the 5-year period beginning on October 1, 2008" for "such sums as may be necessary for fiscal years 2004 through 2008".
Subsec. (b)(3). Pub. L. 110–293, §303(b)(1)(B), substituted "fiscal years 2009 through 2013" for "fiscal years 2004 through 2008".
Subsecs. (c), (d). Pub. L. 110–293, §303(b)(2), added subsecs. (c) relating to statement of policy and (d).
§7634. Malaria response Coordinator
There is established within the United States Agency for International Development a Coordinator of United States Government Activities to Combat Malaria Globally (referred to in this section as the "Malaria Coordinator"), who shall be appointed by the President.
(1) operate internationally to carry out prevention, care, treatment, support, capacity development, and other activities to reduce the prevalence, mortality, and incidence of malaria;
(2) provide grants to, and enter into contracts and cooperative agreements with, nongovernmental organizations (including faith-based organizations) to carry out this section; and
(3) transfer and allocate executive branch agency funds that have been appropriated for the purposes described in paragraphs (1) and (2).
(A) facilitate program and policy coordination of antimalarial efforts among relevant executive branch agencies and nongovernmental organizations by auditing, monitoring, and evaluating such programs;
(B) ensure that each relevant executive branch agency undertakes antimalarial programs primarily in those areas in which the agency has the greatest expertise, technical capability, and potential for success;
(C) coordinate relevant executive branch agency activities in the field of malaria prevention and treatment;
(D) coordinate planning, implementation, and evaluation with the Global AIDS Coordinator in countries in which both programs have a significant presence;
(E) coordinate with national governments, international agencies, civil society, and the private sector; and
(F) establish due diligence criteria for all recipients of funds appropriated by the Federal Government for malaria assistance.
(d) Assistance for the World Health Organization
(e) Coordination of assistance efforts
(1) relevant executive branch agencies, including—
(A) the Department of State (including the Office of the Global AIDS Coordinator);
(D) the Office of the United States Trade Representative;
(2) relevant multilateral institutions, including—
(B) the United Nations Children's Fund;
(C) the United Nations Development Programme;
(D) the Global Fund;
(E) the World Bank; and
(F) the Roll Back Malaria Partnership;
(3) program delivery and efforts to lift barriers that would impede effective and comprehensive malaria control programs; and
(4) partner or recipient country governments and national entities including universities and civil society organizations (including faith- and community-based organizations).
(A) the countries and activities to which malaria resources have been allocated;
(B) the number of people reached through malaria assistance programs, including data on children and pregnant women;
(C) research efforts to develop new tools to combat malaria, including drugs and vaccines;
(D) the collaboration and coordination of United States antimalarial efforts with the World Health Organization, the Global Fund, the World Bank, other donor governments, major private efforts, and relevant executive agencies;
(E) the coordination of United States antimalarial efforts with the national malarial strategies of other donor or partner governments and major private initiatives;
(F) the estimated impact of United States assistance on childhood mortality and morbidity from malaria;
(G) the coordination of antimalarial efforts with broader health and development programs; and
(H) the constraints on implementation of programs posed by health workforce shortages or capacities; and
(I) the number of personnel trained as health workers and the training levels achieved.
(Pub. L. 108–25, title III, §304, May 27, 2003, 117 Stat. 737; Pub. L. 110–293, title III, §304, July 30, 2008, 122 Stat. 2961.)
This chapter, referred to in subsecs. (f) and (g), was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
2008—Pub. L. 110–293 amended section generally. Prior to amendment, section consisted of subsecs. (a) to (h) relating to a pilot program for the placement of health care professionals in overseas areas severely affected by HIV/AIDS, tuberculosis, and malaria.
(1) a description of the activities of relevant executive branch agencies with respect to—
(Pub. L. 108–25, title III, §305, May 27, 2003, 117 Stat. 739.)
§7636. Study on illegal diversions of prescription drugs
Not later than 180 days after May 27, 2003, the Secretary of Health and Human Services, in coordination with other agencies, shall submit a report to the Congress that includes the following:
(1) A thorough accounting of evidence indicating illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts, and an estimate of the extent of such diversion.
(2) Recommendations to increase the administrative and enforcement powers of the United States to identify, monitor, and prevent the illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts.
(3) Recommendations and guidelines to advise and provide technical assistance to developing countries on how to implement a program that minimizes diversion into the United States of prescription drugs donated or sold for humanitarian efforts.
(Pub. L. 108–25, title III, §307, May 27, 2003, 117 Stat. 740.)
Part B—Assistance for Women, Children, and Families
(Pub. L. 108–25, title III, §311, May 27, 2003, 117 Stat. 740.)
The 5-year United States Government strategy required by section 7611 of this title shall—
The Global AIDS Coordinator shall establish a panel of experts to be known as the Prevention of Mother-to-Child Transmission Panel (referred to in this subsection as the "Panel") to—
The Panel shall be convened and chaired by the Global AIDS Coordinator, who shall serve as a nonvoting member. The Panel shall consist of not more than 15 members (excluding the Global AIDS Coordinator), to be appointed by the Global AIDS Coordinator not later than 1 year after July 30, 2008, including—
(Pub. L. 108–25, title III, §312, May 27, 2003, 117 Stat. 741; Pub. L. 110–293, title III, §§307, 309, July 30, 2008, 122 Stat. 2963, 2964.)
This chapter, referred to in subsecs. (b)(2), (6) and (c)(1), (2), was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
2008—Subsec. (b)(1) to (6). Pub. L. 110–293, §307, added pars. (1) to (6) and struck out former pars. (1) to (3) which read as follows:
(2) a description of efforts made by the relevant executive branch agencies to expand those activities, including—
(Pub. L. 108–25, title III, §313, May 27, 2003, 117 Stat. 741; Pub. L. 110–293, title III, §308, July 30, 2008, 122 Stat. 2964.)
2008—Subsec. (a). Pub. L. 110–293 substituted "10 years" for "5 years".
The program should—
(Pub. L. 108–25, title III, §314, May 27, 2003, 117 Stat. 742.)
Amounts provided under a grant awarded under paragraph (1) shall be used—
To be eligible to receive a subgrant under paragraph (1), an entity shall—
(B) demonstrate to the awarding organization that such entity—
(B) the term "international organization" means—
In awarding subgrants under this subsection, the organization should—
An eligible entity awarded a subgrant under this subsection shall use subgrant funds to expand activities to prevent mother-to-child transmission of HIV by providing medical treatment and care and support services to parents and their children, which may include—
The President shall require that each organization awarded a grant under subsection (b)(1) to submit an annual report that includes—
(Pub. L. 108–25, title III, §315, May 27, 2003, 117 Stat. 743.)
§7671. Authorization of appropriations
There are authorized to be appropriated to the President to carry out this chapter and the amendments made by this chapter $48,000,000,000 for the 5-year period beginning on October 1, 2008.
Amounts appropriated pursuant to the authorization of appropriations in subsection (a) are authorized to remain available until expended.
(c) Availability of authorizations
Authorizations of appropriations under subsection (a) shall remain available until the appropriations are made.
(Pub. L. 108–25, title IV, §401, May 27, 2003, 117 Stat. 745; Pub. L. 110–293, title IV, §401(a), July 30, 2008, 122 Stat. 2966.)
This chapter, referred to in subsec. (a), was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
2008—Subsec. (a). Pub. L. 110–293 substituted "$48,000,000,000 for the 5-year period beginning on October 1, 2008" for "$3,000,000,000 for each of the fiscal years 2004 through 2008".
§7672. Sense of Congress
(a) Increase in HIV/AIDS antiretroviral treatment
It is a sense of the Congress that an urgent priority of United States assistance programs to fight HIV/AIDS should be the rapid increase in distribution of antiretroviral treatment so that—
(1) by the end of fiscal year 2004, at least 500,000 individuals with HIV/AIDS are receiving antiretroviral treatment through United States assistance programs;
(2) by the end of fiscal year 2005, at least 1,000,000 such individuals are receiving such treatment; and
(3) by the end of fiscal year 2006, at least 2,000,000 such individuals are receiving such treatment.
(b) Effective distribution of HIV/AIDS funds
It is the sense of Congress that, of the amounts appropriated pursuant to the authorization of appropriations under section 7671 of this title for HIV/AIDS assistance, 10 percent should be used for orphans and vulnerable children.
(Pub. L. 108–25, title IV, §402, May 27, 2003, 117 Stat. 745; Pub. L. 110–293, title IV, §402, July 30, 2008, 122 Stat. 2966.)
2008—Subsec. (b). Pub. L. 110–293 substituted "10 percent should be used" for "an effective distribution of such amounts would be—
"(1) 55 percent of such amounts for treatment of individuals with HIV/AIDS;
"(2) 15 percent of such amounts for palliative care of individuals with HIV/AIDS;
"(3) 20 percent of such amounts for HIV/AIDS prevention consistent with section 2151b–2(d) of this title, of which such amount at least 33 percent should be expended for abstinence-until-marriage programs; and
"(4) 10 percent of such amounts".
§7673. Allocation of funds
(a) Balanced funding requirement
(A) provide balanced funding for prevention activities for sexual transmission of HIV/AIDS; and
(B) ensure that activities promoting abstinence, delay of sexual debut, monogamy, fidelity, and partner reduction are implemented and funded in a meaningful and equitable way in the strategy for each host country based on objective epidemiological evidence as to the source of infections and in consultation with the government of each host county 1 involved in HIV/AIDS prevention activities.
(2) Prevention strategy
In carrying out paragraph (1), the Global AIDS Coordinator shall establish an HIV sexual transmission prevention strategy governing the expenditure of funds authorized under this chapter to prevent the sexual transmission of HIV in any host country with a generalized epidemic.
In each host country described in subparagraph (A), if the strategy established under subparagraph (A) provides less than 50 percent of the funds described in subparagraph (A) for activities promoting abstinence, delay of sexual debut, monogamy, fidelity, and partner reduction, the Global AIDS Coordinator shall, not later than 30 days after the issuance of this strategy, report to the appropriate congressional committees on the justification for this decision.
Programs and activities that implement or purchase new prevention technologies or modalities, such as medical male circumcision, public education about risks to acquire HIV infection from blood exposures, promoting universal precautions, investigating suspected nosocomial infections, pre-exposure pharmaceutical prophylaxis to prevent transmission of HIV, or microbicides and programs and activities that provide counseling and testing for HIV or prevent mother-to-child prevention of HIV, shall not be included in determining compliance with paragraph (2).
Not later than 1 year after July 30, 2008, and annually thereafter as part of the annual report required under section 2151b–2(e) of this title, the President shall—
(A) submit a report on the implementation of paragraph (2) for the most recently concluded fiscal year to the appropriate congressional committees; and
(B) make the report described in subparagraph (A) available to the public.
(b) Orphans and vulnerable children
For fiscal years 2009 through 2023, not less than 10 percent of the amounts appropriated or otherwise made available to carry out the provisions of section 2151b–2 of this title for HIV/AIDS assistance for each such fiscal year shall be expended for assistance for orphans and other children affected by, or vulnerable to, HIV/AIDS, of which such amount at least 50 percent shall be provided through non-profit, nongovernmental organizations, including faith-based organizations, that implement programs on the community level.
For each of the fiscal years 2009 through 2023, more than half of the amounts appropriated or otherwise made available to carry out the provisions of section 2151b–2 of this title shall be expended for—
(1) antiretroviral treatment for HIV/AIDS;
(2) clinical monitoring of HIV-seropositive people not in need of antiretroviral treatment;
(3) care for associated opportunistic infections;
(4) nutrition and food support for people living with HIV/AIDS; and
(5) other essential HIV/AIDS-related medical care for people living with HIV/AIDS.
(d) Treatment, prevention, and care goals
For each of the fiscal years 2009 through 2013—
(1) the treatment goal under section 7672(a)(3) of this title shall be increased above 2,000,000 by at least the percentage increase in the amount appropriated for bilateral global HIV/AIDS assistance for such fiscal year compared with fiscal year 2008;
(2) any increase in the treatment goal under section 7672(a)(3) of this title above the percentage increase in the amount appropriated for bilateral global HIV/AIDS assistance for such fiscal year compared with fiscal year 2008 shall be based on long-term requirements, epidemiological evidence, the share of treatment needs being met by partner governments and other sources of treatment funding, and other appropriate factors;
(3) the treatment goal under section 7672(a)(3) of this title shall be increased above the number calculated under paragraph (1) by the same percentage that the average United States Government cost per patient of providing treatment in countries receiving bilateral HIV/AIDS assistance has decreased compared with fiscal year 2008; and
(4) the prevention and care goals established in clauses (i) and (iv) of section 2151b–2(b)(1)(A) of this title shall be increased consistent with epidemiological evidence and available resources.
(Pub. L. 108–25, title IV, §403, May 27, 2003, 117 Stat. 746; Pub. L. 110–293, title IV, §403, July 30, 2008, 122 Stat. 2966; Pub. L. 113–56, §6, Dec. 2, 2013, 127 Stat. 654; Pub. L. 115–305, §4, Dec. 11, 2018, 132 Stat. 4403.)
This chapter, referred to in subsec. (a)(2)(A), was in the original "this Act", meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables.
2018—Subsec. (b). Pub. L. 115–305, §4(1), substituted "2023" for "2018".
Subsec. (c). Pub. L. 115–305, §4(2), substituted "2023" for "2018" in introductory provisions.
2013—Subsec. (b). Pub. L. 113–56, §6(a), substituted "2018" for "2013" and "amounts appropriated or otherwise made available to carry out the provisions of section 2151b–2 of this title" for "amounts appropriated pursuant to the authorization of appropriations under section 7671 of this title".
Subsec. (c). Pub. L. 113–56, §6(b), substituted "2018" for "2013" and "amounts appropriated or otherwise made available to carry out the provisions of section 2151b–2 of this title" for "amounts appropriated for bilateral global HIV/AIDS assistance pursuant to section 7671 of this title" in introductory provisions.
2008—Subsec. (a). Pub. L. 110–293, §403(1), amended subsec. (a) generally. Prior to amendment, text read as follows: "For fiscal years 2006 through 2008, not less than 55 percent of the amounts appropriated pursuant to the authorization of appropriations under section 7671 of this title for HIV/AIDS assistance for each such fiscal year shall be expended for therapeutic medical care of individuals infected with HIV, of which such amount at least 75 percent should be expended for the purchase and distribution of antiretroviral pharmaceuticals and at least 25 percent should be expended for related care. For fiscal years 2006 through 2008, not less than 33 percent of the amounts appropriated pursuant to the authorization of appropriations under section 7671 of this title for HIV/AIDS prevention consistent with section 2151b–2(d) of this title for each such fiscal year shall be expended for abstinence-until-marriage programs."
Subsec. (b). Pub. L. 110–293, §403(2), substituted "fiscal years 2009 through 2013" for "fiscal years 2006 through 2008" and "other children affected by, or vulnerable to," for "vulnerable children affected by".
Subsecs. (c), (d). Pub. L. 110–293, §403(3), added subsecs. (c) and (d).
1 So in original. Probably should be "country".
§7674. Assistance from the United States private sector to prevent and reduce HIV/AIDS in sub-Saharan Africa
(Pub. L. 108–25, title IV, §404, May 27, 2003, 117 Stat. 746.)
§7681. Report on expansion of debt relief to non-HIPC countries
(1) the options and costs associated with the expansion of debt relief provided by the Enhanced HIPC Initiative to include poor countries that were not eligible for inclusion in the Enhanced HIPC Initiative;
(2) options for burden-sharing among donor countries and multilateral institutions of costs associated with the expansion of debt relief; and
(3) options, in addition to debt relief, to ensure debt sustainability in poor countries, particularly in cases when the poor country has suffered an external economic shock or a natural disaster.
In this section, the term "Enhanced HIPC Initiative" means the multilateral debt initiative for heavily indebted poor countries presented in the Report of G–7 Finance Ministers on the Cologne Debt Initiative to the Cologne Economic Summit, Cologne, June 18–20, 1999.
(Pub. L. 108–25, title V, §502, May 27, 2003, 117 Stat. 749.)
§7682. Authorization of appropriations
There are authorized to be appropriated to the President such sums as may be necessary for the fiscal year 2004 and each fiscal year thereafter to carry out section 262p–8 of this title.
Amounts appropriated pursuant to subsection (a) are authorized to remain available until expended.
(Pub. L. 108–25, title V, §503, May 27, 2003, 117 Stat. 749.)